| Name | Value |
|---|---|
| CODE | 104132 |
| COMPONENT | HUMAN PAPILLOMA VIRUS 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNA |
| CHECK DIGIT | 6 |
| PROPERTY | IMPRESSION/INTERPRETATION OF STUDY |
| DATE LAST CHANGED | 2024-02-27 00:00:00 |
| CHANGE TYPE | ADD |
| TIME ASPECT | POINT |
| SYSTEM | CERVIX |
| SCALE TYPE | Nominal |
| METHOD TYPE | PROBE AMP TAR |
| CLASS | MICRO |
| FULLY SPECIFIED NAME | HUMAN PAPILLOMA VIRUS 16 & 18 & 45 & 31+33+52+58 & 35+39+51+56+59+66+68 DNA:IMP:PT:CVX:NOM:PROBE.AMP.TAR |
| SHORTNAME | HPV16+18+H RISK 14 DNA CVX NAA+PROBE-IMP |
| LONG COMMON NAME | HUMAN PAPILLOMA VIRUS 16 AND 18 AND 31 AND 45+33+52+58 AND 35+39+51+56+59+66+68 DNA [INTERPRETATION] IN CERVIX BY NAA WITH PROBE DETECTION |
| COMMENTS | This term was created for, but not limited in use to, the Alinity High Risk HPV test kit which detects 14 HR HPV genotypes (HPV 16, 18, 31, 33, 35, 39, 45,51, 5 2, 56, 58, 59, 66, and 68) is achieved through a primer mix targeting a conserve d region of the HPV genomes and single stranded DNA probes. This test identifies high-risk (HR) HPV types 16, 18, 45, while reporting the concurrent detection o f the other HR genotypes (31/33/52/58) and (35/39/51/56/59/66/68). This test is indicated for use in routine cervical cancer screening. |
| MASTER ENTRY FOR VUID | YES |
| VUID | 5373520 |
| EFFECTIVE DATE/TIME |
|